Author:
Favretto Donata,Stocchero Giulia,Vogliardi Susanna,Frison Giampietro,Trevisanuto Daniele,Castagna Franca,Ferrara Santo Davide
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference48 articles.
1. Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.;Muth;Biochem Pharmacol,1986
2. An eight-week, open-label, uncontrolled, multicenter, Phase IV study of remission rates in outpatients and inpatients with major depression treated with venlafaxine.;Muth;Drug Dev Res,1991
3. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.;Kaplan;Clin Ther,2002
4. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.;De Nayer;Int J Neuropsychopharmacol,2002
5. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection.;Mandrioli;Chromatogr B Analyt Technol Biomed Life Sci,2007
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献